Signalling via the hypoxia-inducible factor-1α requires multiple posttranslational mofications

被引:174
|
作者
Brahimi-Horn, C [1 ]
Mazure, N [1 ]
Pouysségur, J [1 ]
机构
[1] CNRS, Inst Signaling Dev Biol & Canc Res, CNRS, UMR 6543,Ctr A Lacassagne, F-06189 Nice, France
关键词
angiogenesis; arrest defective-protein; cancer; hypoxia; hypoxia-inducible factor; posttranslational modification; prolyl-4-hydroxylase;
D O I
10.1016/j.cellsig.2004.04.010
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cellular hypoxia, a local decrease in the oxygen concentration below normal (21%) atmospheric concentrations, occurs in both physiological and pathological situations. The transcriptional complex Hypoxia-Inducible Factor-1 (HIF-1) is the key player in the signalling pathway that controls the hypoxic response of mammalian cells. Tight regulation of this response involves posttranslational modification of the alpha subunit of HIF-1. Hydroxylation, ubiquitination, acetylation, S-nitrosation and phosphorylation have been shown to determine its half-life and/or transcriptional activity. The precise spatio-temporal occurrence of these multiple modifications is still not fully understood but is dependent on the microenvironment and determines the driving force of variable cellular responses. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [41] Hypoxia-Inducible Factor-1α and Autoimmune Lupus, Arthritis
    Yang, Zu-Cheng
    Liu, Yi
    INFLAMMATION, 2016, 39 (03) : 1268 - 1273
  • [42] Honokiol inhibits hypoxia-inducible factor-1 pathway
    Lan, Keng-Li
    Lan, Keng-Hsin
    Sheu, Meei-Ling
    Chen, Ming-Yuan
    Shih, Yi-Sheng
    Hsu, Fu-Chih
    Wang, Hong-Ming
    Liu, Ren-Shyan
    Yen, Sang-Hue
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2011, 87 (06) : 579 - 590
  • [43] Dexamethasone impairs hypoxia-inducible factor-1 function
    Wagner, A. E.
    Huck, G.
    Stiehl, D. P.
    Jelkmann, W.
    Hellwig-Buergel, T.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 372 (02) : 336 - 340
  • [44] Cancer Therapy By Targeting Hypoxia-Inducible Factor-1
    Li, Y.
    Ye, D.
    CURRENT CANCER DRUG TARGETS, 2010, 10 (07) : 782 - 796
  • [45] Hypoxia-inducible factor-1α and the glycolytic phenotype in tumors
    Robey, IF
    Lien, AD
    Welsh, SJ
    Baggett, BK
    Gillies, RJ
    NEOPLASIA, 2005, 7 (04): : 324 - 330
  • [46] Hypoxia-inducible factor-1α regulation of myeloid cells
    C. L. Stothers
    L. Luan
    B. A. Fensterheim
    J. K. Bohannon
    Journal of Molecular Medicine, 2018, 96 : 1293 - 1306
  • [47] Synthesis of Neolamellarin A, an Inhibitor of Hypoxia-inducible Factor-1
    Arafeh, Khaled M.
    Ullah, Nisar
    NATURAL PRODUCT COMMUNICATIONS, 2009, 4 (07) : 925 - 926
  • [48] Okadaic acid promotes angiogenesis via activation of hypoxia-inducible factor-1
    Kim, Young-Sun
    Ahn, Kook-Hee
    Kim, Seon-Ye
    Jeong, Joo-Won
    CANCER LETTERS, 2009, 276 (01) : 102 - 108
  • [49] Epolones induce erythropoietin expression via hypoxia-inducible factor-1α activation
    Wanner, RM
    Spielmann, P
    Stroka, DM
    Camenisch, G
    Camenisch, I
    Scheid, A
    Houck, DR
    Bauer, C
    Gassmann, M
    Wenger, RH
    BLOOD, 2000, 96 (04) : 1558 - 1565
  • [50] Variations in hypoxia-inducible factor-1α in cardiac infarction
    Skrlec, Ivana
    Dzijan, Snjezana
    Talapko, Jasminka
    Cesar, Vera
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1389 - 1389